Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Japanese Journal of Clinical Oncology|July 17, 2014
A case report of epithelioid inflammatory myofibroblastic sarcoma with RANBP2-ALK fusion gene treated with the ALK inhibitor, crizotinibShiro Kimbara, Koji Takeda, Hiroko Fukushima, et al.
International Journal of Clinical Oncology|December 8, 2009
Comparison of chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small cell lung cancerHideyuki Harada, Nobuyuki Yamamoto, Toshiaki Takahashi, et al.
Japanese Journal of Clinical Oncology|January 14, 2009
Evaluation of the safety and compliance of 3-week cycles of vinorelbine on days 1 and 8 and cisplatin on day 1 as adjuvant chemotherapy in Japanese patients with completely resected pathological stage IB to IIIA non-small cell lung cancer: a retrospective studyTakehito Shukuya, Toshiaki Takahashi, Akihiro Tamiya, et al.
Lung Cancer (Amsterdam, Netherlands)|August 25, 2009
Comparison of chemotherapy for unresectable pulmonary high-grade non-small cell neuroendocrine carcinoma and small-cell lung cancerSatoshi Igawa, Reiko Watanabe, Ichiro Ito, et al.
Anticancer Research|July 15, 2009
Gefitinib plus paclitaxel after failure of gefitinib in non-small cell lung cancer initially responding to gefitinibTakehito Shukuya, Toshiaki Takahashi, Akihiro Tamiya, et al.
Investigational New Drugs|August 27, 2013
A phase II study of cisplatin /S-1 in patients with carcinomas of unknown primary siteAsuka Tsuya, Takayasu Kurata, Akihiro Tamiya, et al.
Respiratory Investigation|March 10, 2015
Disease flare after gefitinib discontinuationHiroaki Akamatsu, Akira Ono, Takehito Shukuya, et al.
International Journal of Clinical Oncology|February 24, 2012
The role of βIII-tubulin in non-small cell lung cancer patients treated by taxane-based chemotherapyKyoichi Kaira, Toshiaki Takahashi, Haruyasu Murakami, et al.
American Journal of Clinical Oncology|February 8, 2013
Efficacy of rechallenge chemotherapy in patients with sensitive relapsed small cell lung cancerKazushige Wakuda, Hirotsugu Kenmotsu, Tateaki Naito, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 19, 2014
[Evaluation of recurrence rates on change in hormone receptor and human epidermal growth factor receptor 2 status after neo-adjuvant chemotherapy in breast cancer patients]Shinya Tokunaga, Katsumi Ikeda, Yoshinari Ogawa, et al.
Pageof 7